{
  "trial_id": "NCT04399018",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age at enrollment \u226518 years",
      "label": "met"
    },
    {
      "criterion": "Clinical suspicion of MDS",
      "label": "unknown"
    },
    {
      "criterion": "Indication for bone marrow examination",
      "label": "met"
    },
    {
      "criterion": "\u22651 peripheral blood cytopenia defined by hemoglobin concentration <12 g/dL for female and <13g/dL for male patients, platelet count <150 x109/L, absolute neutrophil count <1.8 x109/L",
      "label": "met"
    },
    {
      "criterion": "Inpatient and outpatient care patients",
      "label": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Recruitment: Participants will be included in the study once all the screening activities are completed.",
      "label": "triggers"
    },
    {
      "criterion": "History of or active documented MDS",
      "label": "triggers"
    }
  ],
  "notes": "Patient has a confirmed diagnosis of Wegener's granulomatosis and is being treated with corticosteroid and cyclophosphamides. He has a positive serum MPO-ANCA in his medical record.",
  "_meta": {
    "topic_id": "54",
    "trial_id": "NCT04399018",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}